Until we get into the clinic this is where we'll stay, unless news drops of a partner or buyout. Patience is more important now than ever before as we draw closer to 4Q17. The IND is being drafted, trial locations are being chosen as we speak and we'll be able to begin the trial immediately following the mandatory thirty-day waiting period.
News 
Market Data 
Discover 
AI
